Prevention strategies against human papillomavirus in males (Q37688509)

22 August 2017

1 reference

title

Prevention strategies against human papillomavirus in males (English)

1 reference

22 August 2017

main subject

human papilloma virus

1 reference

human papillomavirus

29 September 2024

Suzanne Marie Garland

series ordinal

1

object named as

Suzanne M Garland

1 reference

22 August 2017

language of work or name

English

0 references

publication date

16 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

117

1 reference

22 August 2017

issue

2 Suppl

1 reference

22 August 2017

page(s)

S20-5

1 reference

The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

The global health burden of infection-associated cancers in the year 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Patterns of treatment of external genital warts in Australian sexual health clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

The psychosocial burden of human papillomavirus related disease and screening interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Anal cancer prevention in HIV-positive men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Anal cancer screening in men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Human papillomavirus and circumcision: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Prostitution, condom use, and invasive squamous cell cervical cancer in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Male influences on cervical cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Model for assessing human papillomavirus vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

The theoretical population-level impact of a prophylactic human papilloma virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.01.027

10.1016/J.YGYNO.2010.01.027

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference